ATLAS / Macro Radar / Reporting / RVMD

Revolution Medicines, Inc. (RVMD) reporting calendar

Revolution Medicines, Inc. files periodic reports with the SEC as RVMD on Nasdaq. Atlas tracks 26 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
27 Jul 2026 – 16 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
6 May 2026
Reports on record
26

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open RVMD market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20266 May 202636 days0001193125-26-208969
10-K31 Dec 202525 Feb 202656 days0001193125-26-071563
10-Q30 Sep 20255 Nov 202536 days0001193125-25-266923
10-Q30 Jun 20256 Aug 202537 days0000950170-25-104022
10-Q31 Mar 20257 May 202537 days0000950170-25-065660
10-K31 Dec 202426 Feb 202557 days0000950170-25-027736
10-Q30 Sep 20246 Nov 202437 days0000950170-24-122303
10-Q30 Jun 20247 Aug 202438 days0000950170-24-092783
10-Q31 Mar 20248 May 202438 days0000950170-24-055655
10-K31 Dec 202326 Feb 202457 days0000950170-24-020145
10-Q30 Sep 20236 Nov 202337 days0000950170-23-059391
10-Q30 Jun 20238 Aug 202339 days0000950170-23-039805
10-Q31 Mar 20238 May 202338 days0000950170-23-018805
10-K31 Dec 202227 Feb 202358 days0000950170-23-004645
10-Q30 Sep 20227 Nov 202238 days0000950170-22-022590
10-Q30 Jun 20229 Aug 202240 days0000950170-22-016059
10-Q31 Mar 20229 May 202239 days0000950170-22-008496
10-K31 Dec 202128 Feb 202259 days0000950170-22-002297
10-Q30 Sep 202110 Nov 202141 days0001564590-21-056191
10-Q30 Jun 202111 Aug 202142 days0001564590-21-043424
10-Q31 Mar 202110 May 202140 days0001564590-21-026054
10-K31 Dec 20202 Mar 202161 days0001564590-21-010276
10-Q30 Sep 202012 Nov 202043 days0001564590-20-053333
10-Q30 Jun 202010 Aug 202041 days0001564590-20-038663
10-Q31 Mar 202014 May 202044 days0001564590-20-025452
10-K31 Dec 201930 Mar 202090 days0001564590-20-014169

Source: SEC EDGAR company submissions for CIK 0001628171. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.